Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

23. Mai 2025 07:15 ET | Quelle: Sol-Gel Technologies Ltd.

Sol-Gel Reports First Quarter 2025 Results

Sol-Gel Reports First Quarter 2025 Results
20. November 2024 07:00 ET | Quelle: Sol-Gel Technologies Ltd.

Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement

Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement
20. Mai 2024 07:00 ET | Quelle: Sol-Gel Technologies Ltd.

Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates

Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates
16. Mai 2024 06:00 ET | Quelle: Sol-Gel Technologies Ltd.

Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel

Sol-Gel and Beimei Pharma annouce an Asset Purcase Agreement to commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel
01. April 2024 07:00 ET | Quelle: Sol-Gel Technologies Ltd.

Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream

Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
13. März 2024 07:00 ET | Quelle: Sol-Gel Technologies Ltd.

Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments

Sol-Gel Reports Full Year 2023 Financial Results and Corporate Developments